Mirae Asset Global Investments »

Silverback Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $91k 17k 5.48
2023-09-30 $62k 16k 3.78
2023-06-30 $109k 16k 6.70